REAL-WORLD EXPOSURE-RESPONSE RELATIONSHIP OF VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE: A POOLED MULTICENTRE OBSERVATIONAL COHORT ANALYSIS OF CLINICAL AND MODELED PHARMACOLOGICAL DATA

Niels Vande Casteele  ¹     William Sandborn  ¹     Brian G. Feagan  ²     Severine Vermeire  ³     Parambir Dulai  ³     Julian Panés  ⁴     Andres Yarur  ⁵     Xavier Roblin  ⁶     Shomron Ben-Horin  ⁷     Iris Dotan  ⁸     Mark Osterman  ⁹     Dirk Lindner  ¹⁰     Christian Agboton  ¹⁰     Maria Rosario  ¹¹     Teresa Osborn  ^12    
1 University of California San Diego, La Jolla, United States
² Robarts Clinical Trials, Western University, London, Canada
³ University Hospitals Leuven, Leuven, Belgium
⁴ Hospital Clinic de Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain
⁵ Medical College of Wisconsin, Milwaukee, United States
⁶ Centre Hospitalier Universitaire de Saint-Etienne, Saint-Etienne, France
⁷ Sheba Medical Center, Tel Aviv University, Tel Hashomer, Israel
⁸ Rabin Medical Center, Petah Tikva, Israel
⁹ University of Pennsylvania Perelman School of Medicine, Philadelphia, United States
¹⁰ Takeda, Zurich, Switzerland
¹¹ Takeda, Cambridge, United States
¹² Takeda, Chicago, United States

Session
IBD Clinical II

Conference
UEG Week Virtual 2020

Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)